What's New

You can now access and download a free copy of the new issue of our newsletter, the NY TBI Model System News.

New Publication Issue

TBI Research Review summarizes current research on traumatic brain injury (TBI), offers suggestions for future research planning and suggests application of research findings to clinical practice and policy. The focus in this first issue is on POST-TBI DEPRESSION. We hope that you find this publication useful and strongly encourage you to email us your feedback. This document may be downloaded and distributed to interested individuals and organizations without cost.

Research Volunteers Are Needed!

The New York TBI Model System at Mount Sinai School of Medicine is seeking people who have had a traumatic brain injury and are experiencing depression. The research study will evaluate the effectiveness of the drug Zoloft, an anti-depressant, in helping individuals who are depressed after brain injury.

To be in this study you must be suffering from depression and be willing to try this medication for a period of 12 weeks. Participants will be randomly assigned, to receive either Zoloft or a sugar pill that contains no medicine. Then you will be asked to visit Mount Sinai every two weeks to monitor whether changes occur in your level of depression. You will be paid for your time.

If interested, please call 866-528-7490. GCO #02-0677 IRB approved through 09/04.

The New York TBI Model System at Mount Sinai School of Medicine is seeking people who have had a traumatic brain injury. The research study focuses on fatigue after brain injury. We want to study how and when fatigue happens and the effects it has on the lives of people with brain injuries.

In this study you will be asked to answer questions about how much fatigue you experience, your health, and your quality of life. You will also be asked to do some tests of thinking abilities, such as memory and attention, to see how fatigue affects your thinking. You will be paid for your time.

If interested, please call 866-528-7490. GCO #02-0677 IRB approved through 09/04.